Swaminathan A, Torresi J, Schlagenhauf P, Thursky K, Wilder-Smith A,
Connor BA, Schwartz E, von Sonnenberg F, Keystone J, O'Brien DP, for the
GeoSentinel Network. A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travelers.
J Infect. 2009 Jul;59(1):19-27
Burchard GD, Caumes E, Connor BA, Freedman DO, Jelinek T, Jong EC, von Sonnenburg F, Steffen R, Tsai TF, Wilder-Smith A, Zuckerman J. Expert Opinion on Vaccination of Travelers Against Japanese Encephalitis J Trav Med 2009; 16 (3): 204–216
Chang M, Minaya M, Cheng J, Connor B, Lewis S, Green P. Double-Blind Randomized Controlled Trial of Rifaximin for Small Intestinal Bacterial Overgrowth (SIBO) in Celiac Disease. Amer J Gastro 2009; 104 (S3): S97
Schwartz E, Connor BA Typhoid Infection British Medical Journal BMJ Evidence Epocrates Online 2008-2009
Greenwood Z, Black J, Weld L, O’Brien D, Leder K, von Sonnenburg F, Pandey P, Schwartz E, Connor BA, Brown G, Freedman DO, Torresi J. Gastrointestinal Infection Among International Travelers Globally. J Trav Med 2008; 15(4):221-228
Connor BA, Patron DJ. Use of an Accelerated Immunization Schedule for Combined Hepatitis A and B Protection in the Corporate Traveler. J Occup Environ Med. 2008; 50:945-950
Connor BA, Anderson S, Steffen R. The Use of Combination Vaccines in International Travelers Visiting Countries with High Endemic Rates of Hepatitis A and/or Hepatitis B. Amer J Infect Dis 2008 4(2):104-108
Schiff ER, Connor BA, Hershey JH, Mahoney MC, Schaffner W. Recommendations from a National Conference on Universal Vaccination Against Hepatitis A and Hepatitis B in Adults. J Applied Research 2007;7 (1): 3-16
Marcus LC, Froeschle JE, Hill D, Wolfe MS, Maus D, Connor B, Acosta AM, Rensimer ER, Roberts A, Dardick K. Safety of Typhim Vi Vaccine in a Postmarketing Observational Study. J Trav Med 2007;14(6):386-391.
Connor BA, Blatter MM, Beran J, Zou B Trofa A. Rapid and Sustained Response Against Hepatitis A and B Achieved With Combined Vaccine Using an Accelerated Administration Schedule. J Trav Med 2007; 14:9-15
Connor BA, Jacobs RJ, Meyerhoff AS. Hepatitis B Risks and Immunization Coverage Among American Travelers. J Trav Med 2006; 13:273-280
Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS, for the GeoSentinel Surveillance Network: Ansdell V, Barnett E, Brown G, Torresi J, Carosi G, Castelli F, Chen L, Wilson M, Connor B, Delmont J, Parola P, Gurtman A, Hale D, Gelman S, Piper-Jenks N, Jong E, Kass R, Kain K, Licitra C, Loutan L, Chappuis F, Lynch M, McClellan S, Muller R, Nutman T, Klion A, Perret C, Valdivieso F, Sack B, MacKenzie R, Schwartz E, Shaw M, Steffen R, Schlagenhauf P, Wittner M, Zuckerman J. Spectrum of Disease and Relation to Place of Exposure Among Ill Returned Travelers. N Engl J Med 2006; 354:119-30
Zuckerman JN, Connor BA, von Sonnenburg F. Hepatitis A and B Booster Recommendations: Implication for Travelers. Clin Infect Dis 2005; 41 (7): 1020-1026
Connor BA, Schwartz E. Typhoid and paratyphoid fever in travellers. Lancet Infect Dis 2005; 5: 623-628
Connor, BA. Sequelae of Diarrhea in Travelers: Focus on Post-Infectious Irritable Bowel Syndrome. Clin Infect Dis 2005; 41 (S8): S577-S586
Connor, BA. Hepatitis A Vaccine in the Last Minute Traveler. Am J Med 2005; 118 (10A): 58S-62S
Connor, BA. Trends in Travelers. J Travel Med 2005; 12: S1-S2
Steffen R, Connor, BA. Vaccines in Travel Health: From Risk Assessment to Priorities.
J Travel Med 2005; 12:26-35
Landzberg BR, Connor BA. Persistent diarrhea in the returning traveler: think beyond persistent infection. Scand J Gastroenterol 2005 Jan; 40 (1): 112-14
Hamer DH, Connor BA. Travel Health Knowledge, Attitudes and Practices among United States Travelers. J Travel Med 2004; 11:1-4
Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley G, Leroux-Roels G, von Sonnenburg F, the International Consensus Group on Hepatitis A Virus Immunity. Hepatitis A booster vaccination: is there a need? Consensus Statement. Lancet 2003; 362:1065-1071
Connor BA, Landzberg BR. Hepatitis A and the Traveler. Infections in Medicine 2003;20 (9): 422-423
Connor BA, Landzberg BR. Persistent Travelers’Diarrhea. Infections in Medicine 2003;20 (5): 242-244
Connor BA, Van Herck K, Van Damme P. Rapid protection and vaccination against Hepatitis A for Travellers. BioDrugs 2003; 17 (suppl 1):19-21
Leder K, Sundararajan V, Weld L et. al. and the GeoSentinel Surveillance Group. Respiratory Tract Infections in Travelers: A Review of the GeoSentinel Surveillance Network. Clin Infect Dis 2003;36:399-406
Connor BA. Expert recommendations for antimalarial prophylaxis. J Travel Med 2001;8 (suppl 3):S57-S64
Martin M, Weld L, Tsai T et.al. and the GeoSentinel Yellow Fever Working Group. Advanced age a risk factor for illness temporally associated with Yellow Fever vaccination. Emerg Infect Dis, 2001 7(6):945-951
Connor BA, Johnson E, Soave R. Reiter Syndrome associated with antecedent Cyclospora infection. Emerg Infect Dis, 2001; 7(3):453-454.
Reidenberg, MM, Connor BA, Counterfeit and substandard drugs. J Clin Pharm and Therapeutics, 2001; 69(4):189-193.
Connor BA. Achieving immunization in adults: Opportunities presented by travel clinics in the U.S. J Travel Med, 2001 (suppl) s17-s19.
Connor BA, Phair J, Sack D, McEniry D, Hornick R, Banerjee D, Jensen E, Kuter B. Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix. Clin Infect Dis, 2001; 32:396-401.
Mao HV, Lak BV, Long T, Chung NQ, Thang DM, Hop TV, Chien NN, Hoan PQ,
Henley KS, Connor BA, Stone CD. Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer. Aliment Pharmacol Ther (England), Jan 2000, 14(1) p97-101
Safdar A, Hartman BJ, Connor BA, Murray HW. Pulmonary edema in malaria. Int J Infect Dis, Summer 1999, 3(4):217-219.
Taylor DN, Connor BA, Shlim DR. Chronic Diarrhea in the Returned Traveler. Med Clin North Am, 1999; 83(4):1033-1052.
Freedman DO, Kozarsky PE, Weld LH, Cetron MS and the GeoSentinel Study Group. GeoSentinel: The global emerging infections sentinel network of the International Society of Travel Medicine, J Travel Med, 1999; 6:94-98.
Connor BA, Reidy J, Soave R. Cyclosporiasis: clinical and histopathologic correlates. Clin Infect Dis 1999; 28:1216-22.
Connor BA. Cyclospora: Clinical manifestations. Food and Drug Administration FDA)/Center for Food Safety and Applied Nutrition, Food Advisory Committee Meeting, Federal Register, July 1997
Connor BA. Cyclospora infection: A review. Ann Acad Med Singapore 1997; 26:632-6.
Connor BA, Shlim DR. Foodborne transmission of Cyclospora. Lancet 1995; 346:1634.
Connor BA, Shlim DR, Scholes JV, Rayburn JL, Reidy J, and Rajah R. Pathologic changes in the small bowel in nine patients with diarrhea associated with a coccidia-like body. Ann Intern Med 1993; 119:377-382.
Connor BA, Anderson RJ, Smith JW. Mucor mediastinitis: report of a case. Chest 1979;
75:524-526
